Skip to main content

Advertisement

SpringerLink
Log in

Clinical Outcome and Long-term Remission in JIA

  • Pediatric Rheumatology (S Ozen, Section Editor)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review assesses the long-term remission and predictors of clinical outcome in patients with juvenile idiopathic arthritis (JIA). A comprehensive literature search was performed including articles published between January 1, 2004 and February 28, 2017. Studies, with a minimum follow-up of 24 months, were selected independently by two reviewers based on in- and exclusion criteria. The objective outcome was inactive disease/clinical remission as defined by the Wallace criteria at last follow-up.

Recent Findings

The probability of achieving inactive disease and/or clinical remission is dependent on the JIA subcategories studied in the different articles. Overall, a significant proportion of JIA patients still showed signs of active disease at last follow-up. Some studies include patient populations followed for 15 years or more and these patients were exposed to different treatment protocols at disease presentation than patients diagnosed in the biologic era.

Summary

Although the severity of the morbidity and associated mortality risk has decreased over time, a significant proportion of the current JIA patients still do not reach an inactive disease status within a 2-year follow-up window. Studying the long-term outcome of patients with JIA remains challenging due to the heterogeneity of the study designs and study populations. Although improvement has been shown in the biologic era, we still need to enhance the number of patients with inactive disease within the first 2 years after diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Recently published papers of particular interest have been highlighted as: • Of importance •• Of major importance

  1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.

    PubMed  Google Scholar 

  2. Hill RHHA, Walters K. Juvenile rheumatoid arthritis: follow-up into adulthood—medical, sexual and social status. Can Med Assoc J. 1976;114(9):790–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Viola S, Felici E, Magni-Manzoni S, Pistorio A, Buoncompagni A, Ruperto N, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum. 2005;52(7):2092–102.

    Article  PubMed  Google Scholar 

  4. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40(7):1202–9.

    Article  CAS  PubMed  Google Scholar 

  5. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290–4.

    PubMed  Google Scholar 

  6. Rheumatism ELA. EULAR Bulletin No. 4: nomenclature and classification of arthritis in children. Basel: National Zeitung AG; 1977. p. 3.

    Google Scholar 

  7. Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum. 1977;20(2 Suppl):195–9.

    PubMed  Google Scholar 

  8. Anink J, Dolman KM, van den Merlijn Berg J, van Veenendaal M, Kuijpers TW, van Rossum MA. Two-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients? Clin Exp Rheumatol. 2012;30(6):972–8.

    PubMed  Google Scholar 

  9. Selvaag AM, Flato B, Dale K, Lien G, Vinje O, Smerdel-Ramoya A, et al. Radiographic and clinical outcome in early juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3-year prospective study. J Rheumatol. 2006;33(7):1382–91.

    PubMed  Google Scholar 

  10. Selvaag AM, Lien G, Sorskaar D, Vinje O, Forre O, Flato B. Early disease course and predictors of disability in juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3 year prospective study. J Rheumatol. 2005;32(6):1122–30.

    PubMed  Google Scholar 

  11. Huang HQX, Yu H, Li J, Zhang Y. Clinical analysis in 202 children with juvenile idiopathic arthritis. Clin Rheumatol. 2013;32(7):1021–7.

    Article  PubMed  Google Scholar 

  12. Bertilsson L, Andersson-Gare B, Fasth A, Petersson IF, Forsblad-D’elia H. Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Rheumatol. 2013;40(5):715–24.

    Article  PubMed  Google Scholar 

  13. Bertilsson L, Andersson-Gare B, Fasth A, Forsblad-d'Elia H. A 5-year prospective population-based study of juvenile chronic arthritis: onset, disease process, and outcome. Scand J Rheumatol. 2012;41(5):379–82.

    Article  CAS  PubMed  Google Scholar 

  14. Tsai HY, Lee JH, Yu HH, Wang LC, Yang YH, Chiang BL. Initial manifestations and clinical course of systemic onset juvenile idiopathic arthritis: a ten-year retrospective study. J Formos Med Assoc. 2012;111(10):542–9.

    Article  PubMed  Google Scholar 

  15. Albers HM, Brinkman DM, Kamphuis SS, van Suijlekom-Smit LW, van Rossum MA, Hoppenreijs EP, et al. Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis. Arthritis Care Res. 2010;62(2):204–12.

    CAS  Google Scholar 

  16. Butbul Aviel Y, Tyrrell P, Schneider R, Dhillon S, Feldman BM, Laxer R, et al. Juvenile psoriatic arthritis (JPsA): juvenile arthritis with psoriasis? Pediatr Rheumatol Online. 2013;11(1):11.

    Article  Google Scholar 

  17. Alberdi-Saugstrup M, Enevold C, Zak M, Nielsen S, Nordal E, Berntson L, et al. Nordic Study Group of Pediatric Rheumatology (NoSPeR). Scand J Rheumatol 2017;46(5):1–8.

  18. Sato JFT, Nascimento C, Corrente J, Saad-Magalhaes C. Probability of remission of juvenile idiopathic arthritis following treatment with steroid injection. Clin Exp Rheumatol. 2014;32(2):291–6.

    Google Scholar 

  19. Berntson L, Nordal E, Aalto K, Peltoniemi S, Herlin T, Zak M, et al. HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis. J Rheumatol. 2013;40(5):725–31.

    Article  CAS  PubMed  Google Scholar 

  20. Russo RA, Katsicas MM. Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome. J Rheumatol. 2013;40(3):329–34.

    Article  CAS  PubMed  Google Scholar 

  21. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(9):2809–18.

    Article  PubMed  Google Scholar 

  22. Pagnini I, Savelli S, Matucci-Cerinic M, Fonda C, Cimaz R, Simonini G. Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. J Rheumatol. 2010;37(11):2395–401.

    Article  PubMed  Google Scholar 

  23. Ringold S, Seidel KD, Koepsell TD, Wallace CA. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology (Oxford). 2009;48(8):972–7.

    Article  Google Scholar 

  24. Lurati A, Salmaso A, Gerloni V, Gattinara M, Fantini F. Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases. J Rheumatol. 2009;36(7):1532–5.

    Article  PubMed  Google Scholar 

  25. Flato B, Lien G, Smerdel-Ramoya A, Vinje O. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J Rheumatol. 2009;36(3):642–50.

    Article  PubMed  Google Scholar 

  26. Magnani A, Pistorio A, Magni-Manzoni S, Falcone A, Lombardini G, Bandeira M, et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009;36(3):628–34.

    Article  PubMed  Google Scholar 

  27. Flato B, Hoffmann-Vold AM, Reiff A, Forre O, Lien G, Vinje O. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study. Arthritis Rheum. 2006;54(11):3573–82.

    Article  PubMed  Google Scholar 

  28. Romano M, Pontikaki I, Gattinara M, Ardoino I, Donati C, Boracchi P, et al. Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients. Reumatismo. 2013;65(6):278–85.

    Article  Google Scholar 

  29. • Vastert SJ, de Jager W, Noordman BJ, Holzinger D, Kuis W, Prakken BJ, et al. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. Arthritis Rheumatol. 2014;66(4):1034–43. First study to show the efficacy of a short course of Il-1 blocker on the disease course of systemic JIA

    Article  CAS  PubMed  Google Scholar 

  30. Baszis K, Garbutt J, Toib D, Mao J, King A, White A, et al. Clinical outcomes after withdrawal of anti-tumor necrosis factor alpha therapy in patients with juvenile idiopathic arthritis: a twelve-year experience. Arthritis Rheum. 2011;63(10):3163–8.

    Article  PubMed  Google Scholar 

  31. Wallace CA, Ringold S, Bohnsack J, Spalding SJ, Brunner HI, Milojevic D, et al. Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis. J Rheumatol. 2014;41(12):2459–65.

    Article  PubMed  Google Scholar 

  32. • Selvaag AM, Aulie HA, Lilleby V, Flato B. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis. Ann Rheum Dis. 2016;75(1):190–5. This study is the longest prospective follow-up study on remission in JIA. They use standardized outcome such as the Wallace remission criteria

    Article  PubMed  Google Scholar 

  33. Dewoolkar M, Cimaz R, Chickermane PR, Khubchandani RP. Course, outcome and complications in children with systemic onset juvenile idiopathic arthritis. Indian J Pediatr. 2017;84(4):294–8.

    Article  PubMed  Google Scholar 

  34. Glerup MHT, Twilt M. Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis. Clin Rheumatol. 2017;36(3):671–6.

    Article  CAS  PubMed  Google Scholar 

  35. Ekelund M, Aalto K, Fasth A, Herlin T, Nielsen S, Nordal E, et al. Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis—an eight-year follow-up study. Pediatr Rheumatol Online. 2017;15(1):13.

    Article  Google Scholar 

  36. •• Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Boire G, et al. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort. Ann Rheum Dis. 2015;74(10):1854–60. This is the largest, prospective inception cohort published. They provide information on the probability of achieving remission 5 years after diagnosis

    Article  CAS  PubMed  Google Scholar 

  37. Guzman J, Oen K, Huber AM, Watanabe Duffy K, Boire G, Shiff N, et al. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Ann Rheum Dis. 2015;75(6):1092–8.

    Article  PubMed  Google Scholar 

  38. Berntson L, Damgard M, Andersson-Gare B, Herlin T, Nielsen S, Nordal E, et al. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J Rheumatol. 2008;35(10):2055–61.

    CAS  PubMed  Google Scholar 

  39. Berntson L, Nordal E, Fasth A, Aalto K, Herlin T, Nielsen S, et al. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA). Pediatr Rheumatol Online. 2014;12:22.

    Article  Google Scholar 

  40. Esbjornsson AC, Aalto K, Brostrom EW, Fasth A, Herlin T, Nielsen S, et al. Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2015;33(5):751–7.

    PubMed  Google Scholar 

  41. Papadopoulou C, Kostik M, Gonzalez-Fernandez MI, Bohm M, Nieto-Gonzalez JC, Pistorio A, et al. Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era. Arthritis Care Res. 2013;65(7):1112–20.

    Article  CAS  Google Scholar 

  42. Elhai M, Wipff J, Bazeli R, Freire V, Feydy A, Drape JL, et al. Radiological cervical spine involvement in young adults with polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford). 2013;52(2):267–75.

    Article  Google Scholar 

  43. Batthish M, Feldman BM, Babyn PS, Tyrrell PN, Schneider R. Predictors of hip disease in the systemic arthritis subtype of juvenile idiopathic arthritis. J Rheumatol. 2011;38(5):954–8.

    Article  PubMed  Google Scholar 

  44. Stoll ML, Bhore R, Dempsey-Robertson M, Punaro M. Spondyloarthritis in a pediatric population: risk factors for sacroiliitis. J Rheumatol. 2010;37(11):2402–8.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Nusman CM, Hemke R, Lavini C, Schonenberg-Meinema D, van Rossum MA, Dolman KM, et al. Dynamic contrast-enhanced magnetic resonance imaging can play a role in predicting flare in juvenile idiopathic arthritis. Eur J Radiol. 2017;88:77–81.

    Article  PubMed  Google Scholar 

  46. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492–509.

    Article  CAS  PubMed  Google Scholar 

  47. Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O’Neil KM, Zeft AS, et al. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. J Rheumatol. 2014;41(6):1163–70.

    Article  PubMed  Google Scholar 

  48. Cimaz R. Systemic-onset juvenile idiopathic arthritis. Autoimm Rev. 2016;15(9):931–4.

    Article  CAS  Google Scholar 

  49. Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum. 2005;52(3):826–32.

    Article  PubMed  Google Scholar 

  50. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol. 2002;29(9):1989–99.

    PubMed  Google Scholar 

  51. Fantini F, Gerloni V, Gattinara M, Cimaz R, Arnoldi C, Lupi E. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. J Rheumatol. 2003;30(3):579–84.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Aarhus University Hospital, Palle Juul-Jensens Blvd 99, 8200, Aarhus, Denmark

    Mia Glerup

  2. Department of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark

    T. Herlin & M. Twilt

  3. Department of Pediatrics, Division of Rheumatology, Alberta Children’s Hospital, University of Calgary, Calgary, AB, Canada

    M. Twilt

Authors
  1. Mia Glerup
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Herlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Twilt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mia Glerup.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pediatric Rheumatology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Glerup, M., Herlin, T. & Twilt, M. Clinical Outcome and Long-term Remission in JIA. Curr Rheumatol Rep 19, 75 (2017). https://doi.org/10.1007/s11926-017-0702-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-017-0702-4

Keywords

Search

Navigation